Skip to main content
Decorative image of the AMR Learning Lounge

Rapid diagnostic testing for antimicrobial stewardship: Utility in Asia Pacific


Rapid diagnostic testing (RDT) can provide prompt, accurate identification of infectious organisms and be a key component of antimicrobial stewardship (AMS) programs. However, cost can be prohibitive, particularly in less resource-replete settings. Despite the increasing availability and scope of RDT methods, there is currently no global or regional consensus on what constitutes an RDT. Across Asia Pacific, more data is needed on RDT use within AMS, focusing on the impact on antimicrobial usage, patient morbidity and mortality, and cost effectiveness. By addressing these issues and developing consensus-based statements to guide clinical practice, the outcomes of AMS programs will improve across the region.


The Society for Healthcare Epidemiology of America (SHEA)


Read the SHEA article published by Cambridge University Press.

Estimated reading time: 11 minutes

We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.

U.S. bioMérieux Solutions

US Solutions

Antimicrobial Stewardship Solutions

Antimicrobial Resistance is undermining modern medicine and putting patients at risk of premature death. bioMérieux is committed to preserving antibiotic efficacy with the right diagnostic tests that guide appropriate and responsible use of antibiotics to ensure they remain lifesaving for posterity.


Cambridge University Press
November 30, 2021